Citi raised the firm’s price target on Fortrea (FTRE) to $10 from $7 and keeps a Neutral rating on the shares. The firm adjusted models in the life science tools and diagnostics group ahead of the Q3 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE: